Comment on "A Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder"'

被引：0
|
作者：
Wang, Chenxi [1 ]
Tian, Huichuan [1 ]
Shang, Jin [2 ]
机构：
[1] Macau Univ Sci & Technol, Fac Chinese Med, Taipa 999078, Macao, Peoples R China
[2] Hubei Univ Tradit Chinese Med, Sch Pharm, Wuhan 430065, Peoples R China
来源：
CNS DRUGS | 2025年 / 39卷 / 02期
关键词：
D O I：
10.1007/s40263-024-01152-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [41] Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine
    Sakai, Fumihiko
    Takeshima, Takao
    Tatsuoka, Yoshihisa
    Hirata, Koichi
    Cheng, Sunfa
    Numachi, Yotaro
    Peng, Cheng
    Xue, Fei
    Mikol, Daniel D.
    HEADACHE, 2021, 61 (04): : 653 - 661
  • [42] EFFICACY AND SAFETY OF BREXPIPRAZOLE AS ADJUNCTIVE TREATMENT IN MAJOR DEPRESSIVE DISORDER: OVERVIEW OF FOUR SHORT-TERM STUDIES
    Hobart, M.
    Zhang, P.
    Weiss, C.
    Meehan, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 : 144 - 144
  • [43] Efficacy and safety of brexpiprazole as adjunctive treatment in major depressive disorder: overview of four short-term studies
    Thase, Michael E.
    Zhang, Peter
    Weiss, Catherine
    Meehan, Stine Rasmussen
    Hobart, Mary
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (15) : 1907 - 1916
  • [44] Long-term safety of brodalumab in Japanese patients with plaque psoriasis: An open-label extension study
    Yamaguchi, Yukie
    Takatsu, Nobumichi
    Ootaki, Kenji
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2020, 47 (06): : 569 - 577
  • [45] Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder
    Andersen, SW
    Clemow, DB
    Corya, SA
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (11) : 1468 - 1476
  • [46] Long-term safety and efficacy of a once-daily formulation of alfuzosin 10 mg in patients with symptomatic benign prostatic hyperplasia: Open-label extension study - Editorial comment
    Djavan, B
    EUROPEAN UROLOGY, 2002, 41 (01) : 60 - 61
  • [47] Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study
    Tanaka, Yoshiya
    Curtis, Paula
    DeRose, Kathleen
    Kurrasch, Regina
    Kinoshita, Kyoko
    Tanaka, Rika
    Yamazaki, Yumi
    Roth, David A.
    MODERN RHEUMATOLOGY, 2023, 33 (01) : 122 - 133
  • [48] Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
    Wade, Alan G.
    Crawford, Gordon M.
    Yellowlees, Ann
    BMC PSYCHIATRY, 2011, 11
  • [49] Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
    Alan G Wade
    Gordon M Crawford
    Ann Yellowlees
    BMC Psychiatry, 11
  • [50] Effect of brexpiprazole on long-term remission in adults with schizophrenia: results of an open-label, long-term study
    Baker, R.
    Jin, N.
    Weiller, E.
    Weiss, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S952 - S952
12345